Research-informed explainer · Last reviewed April 11, 2026
Catheter Ablation vs Open-Heart Surgery for AFib
Plain-language comparison of catheter ablation and surgical maze for atrial fibrillation, grounded in peer-reviewed research from leading electrophysiologists.
If your cardiologist has started talking about "fixing" your atrial fibrillation with a procedure, you'll hear two main options: catheter ablation and surgical ablation. They sound similar, but they're very different experiences, and the research is fairly clear about when each one is the right fit.
This explainer walks through how the two procedures work, who each one is typically for, and what large clinical trials have shown about the outcomes. It draws on peer-reviewed research from three cardiac electrophysiologists listed in the Convene directory, including the principal investigator of the CABANA trial and specialists who contributed to the most recent international guidelines on ablation.
What's the difference?
Catheter ablation is done through a thin, flexible tube (a catheter) threaded up to your heart through a vein in your leg. Once it's in place, the doctor uses heat, cold, or pulsed electrical fields to create tiny scars in the heart tissue. Those scars block the abnormal electrical signals that cause atrial fibrillation (AF). You're usually awake under sedation or lightly asleep, the procedure takes a few hours, and most people go home the same day or the next morning.
Surgical ablation, often called the "maze" procedure or Cox-Maze, is heart surgery. A surgeon makes incisions on the heart itself to create a pattern of scar tissue that reroutes the electrical signals. It can be done as open-heart surgery (through the breastbone) or with smaller incisions between the ribs. Recovery takes weeks to months, and it's typically done when you're already having another heart operation, like a valve repair, rather than as a standalone procedure.
For most people with AF, the conversation is really about catheter ablation versus continuing to manage the rhythm with medications. Surgical ablation comes into the picture when you're already going to have heart surgery for another reason, or when catheter ablation hasn't worked.
At a glance
What the major trials actually showed
Does ablation work better than drugs? The CABANA trial, a randomized study of 2,204 patients published in JAMA in 2019, answered that more clearly than any study before it. CABANA compared catheter ablation to antiarrhythmic drug therapy in patients with AF and measured hard outcomes: death, disabling stroke, serious bleeding, and cardiac arrest. When every patient was counted based on the treatment they were assigned (whether or not they actually got it), ablation and drugs came out statistically similar [1].
A companion paper in the same issue of JAMA looked at quality of life instead. Patients who had catheter ablation reported fewer symptoms and less interference with daily life than those on drugs alone [2]. A 2021 follow-up in Circulation zoomed in on the CABANA patients who also had heart failure, and in that subgroup ablation produced real improvements in survival as well as symptom relief [3].
So the picture most electrophysiologists read out of CABANA is this: catheter ablation isn't a guaranteed way to live longer if you have AF, but it's a reliable way to feel better and stay in normal rhythm, and it's especially valuable if your heart function is already starting to slip.
How successful is catheter ablation, really?
It depends on what "success" means and which type of AF you have. An international survey led from Johns Hopkins looked at outcomes from electrophysiology labs worldwide and found that catheter ablation was effective in about 80% of patients after an average of 1.3 procedures, with roughly 70% not needing further antiarrhythmic drugs at intermediate follow-up [4]. A 2014 trial in the Journal of the American College of Cardiology showed that newer catheters with contact-force sensing, which tell the doctor how firmly the tip is pressing on the heart wall, improved the odds of staying AF-free at one year [5].
Success rates are highest for paroxysmal AF (episodes that start and stop on their own) and lower for long-standing persistent AF (AF that's been continuous for more than a year). If your AF has been going for several years without ever converting back to normal rhythm, ask your doctor what success rate they see in patients with your specific type.
When do doctors consider surgery instead?
The 2024 international consensus statement on AF ablation, developed by a large group of electrophysiologists including specialists at UCSF, is fairly direct on this point. Surgical ablation is a Class I recommendation (the strongest category) when a patient with AF is already undergoing open cardiac surgery for something else, like a mitral valve repair or coronary artery bypass. Why? Because the surgeon is already inside the chest, and adding a maze procedure treats the AF at the same time with relatively little extra risk [6].
For patients who are not having other heart surgery, surgical ablation is generally considered only after catheter ablation has been tried and failed, or in select cases with anatomy that makes catheter ablation difficult. The 2017 guidelines on catheter and surgical ablation walk through the comparison in detail and describe who should be considered for each approach [7].
What's changing: pulsed field ablation
The energy source used in catheter ablation has changed. Traditional catheter ablation uses either heat (radiofrequency) or cold (cryoballoon). Both can occasionally damage nearby tissue like the esophagus or the phrenic nerve. A newer technique called pulsed field ablation uses brief electric fields that are more selective for heart muscle and tend to leave those neighboring structures alone.
The ADVENT trial, published in the New England Journal of Medicine in 2023, randomly assigned patients with paroxysmal AF to either pulsed field ablation or conventional thermal ablation. Pulsed field was found to be noninferior, meaning it worked about as well as the standard approach for both preventing AF from coming back and for serious adverse events [8]. The technology is now available at many major electrophysiology centers and is becoming more common as doctors gain experience with it.
Questions to ask your doctor
- Is my AF paroxysmal (comes and goes) or persistent (continuous)? How does that change the odds that ablation will work for me?
- What's your center's one-year success rate for patients like me (same AF type, same age, same heart function)?
- Do you offer pulsed field ablation, and would it be a better fit than radiofrequency or cryoballoon in my case?
- If I'm likely to need other heart surgery in the next few years, should I delay catheter ablation and plan for a combined surgical approach instead?
- What medications will I need to take before and after the procedure, and for how long?
- What does recovery actually look like for me specifically: how soon can I drive, work, and exercise?
The bottom line
For most people with symptomatic AF who haven't responded to medication, catheter ablation is the first procedural option to discuss. The research is clear that it improves quality of life, and in patients with heart failure it appears to improve survival too. Surgical ablation has a narrower role: it's most often considered when you're already having heart surgery for another reason, or when catheter ablation hasn't worked.
Which one is right for you depends on the specifics of your heart and your AF history. Start by asking an experienced electrophysiologist what they'd recommend for someone in your situation, and don't be shy about getting a second opinion if the plan doesn't feel right.
Research informing this article
Peer-reviewed research from the following specialists listed on Convene informs this explainer. They did not write or review the article; their published work is cited throughout.
- Hugh Calkins, M.D.
Professor of Cardiology and Medicine; Director, Clinical Electrophysiology Laboratory
Johns Hopkins Hospital
- Edward Gerstenfeld, MD
Professor of Medicine; Chief of the Section of Cardiac Electrophysiology
UCSF Medical Center
- Douglas Packer, M.D.
Cardiac Electrophysiologist; Principal Investigator, CABANA Trial
Mayo Clinic
Sources
- 1.Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation — JAMA, 2019. DOI
- 2.Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation — JAMA, 2019. DOI
- 3.
- 4.Paroxysmal AF Catheter Ablation With a Contact Force Sensing Catheter — Journal of the American College of Cardiology, 2014. DOI
- 5.Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation — Circulation Arrhythmia and Electrophysiology, 2009. DOI
- 6.2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society — EP Europace, 2012. DOI
- 7.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation — Heart Rhythm, 2017. DOI
- 8.2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation — EP Europace, 2024. DOI
- 9.Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation — New England Journal of Medicine, 2023. DOI
Related articles
cardiology / electrophysiology
Ablation vs Medication for AFib: Which Is Better?
Plain-language comparison of catheter ablation and antiarrhythmic medication for atrial fibrillation, grounded in the CABANA trial and landmark electrophysiology research.
cardiology / electrophysiology
RF Ablation vs Cryoablation for AFib: Key Differences
Plain-language comparison of radiofrequency ablation, cryoablation, and pulsed field ablation for atrial fibrillation, grounded in landmark electrophysiology trials.
oncology
Academic vs Community Cancer Care: Which Is Better?
Choosing between an academic cancer center and a community oncologist? What the research shows about when each setting produces better outcomes.